The global single-use bioprocessing market is expanding rapidly as biopharmaceutical manufacturers increasingly adopt flexible, scalable, and cost-efficient production technologies. Single-use bioprocessing uses disposable components such as bags, tubing, connectors, filters, sensors, bioreactors, and other systems instead of traditional reusable stainless-steel equipment. This approach can reduce cleaning and sterilization requirements, shorten facility preparation time, and lower the risk of cross-contamination.

According to Grand View Research, the global single-use bioprocessing market was valued at USD 37.8 billion in 2025 and is estimated to reach USD 43.7 billion in 2026. The market is projected to reach USD 112.5 billion by 2033, registering a CAGR of 14.5% from 2026 to 2033. North America dominated the market with a 34.7% revenue share in 2025, while Asia Pacific is expected to be the fastest-growing regional market.

Track Market Growth and Metrics

The increasing production of biologics is one of the strongest factors supporting the expansion of single-use bioprocessing. Monoclonal antibodies, vaccines, recombinant proteins, cell therapies, and gene therapies require sophisticated manufacturing environments. Single-use systems provide manufacturers with greater flexibility when producing different products and batch sizes.

Single-use technologies are particularly attractive for companies seeking to accelerate facility commissioning and reduce the infrastructure requirements associated with conventional stainless-steel systems. Contract development and manufacturing organizations are also increasing their use of these technologies because they frequently need to manufacture multiple products for different customers.

Global Revenue Forecast

• Market Size (2025): USD 37.8 billion
• Market Size (2026): USD 43.7 billion
• Projected Value (2033): USD 112.5 billion
• Market CAGR (2026 to 2033): 14.5%
• Dominant Region: North America
• North America Revenue Share (2025): 34.7%
• Fastest-growing Region: Asia Pacific
• Leading Product Segment: Simple and peripheral elements
• Leading Product Share (2025): 48.9%
• Leading Workflow: Upstream
• Upstream Revenue Share (2025): 58.4%
• Leading End Use: Biopharmaceutical manufacturers
• Biopharmaceutical Manufacturer Share (2025): 57.9%

Download a free sample copy of the Single-use Bioprocessing market report to understand detailed coverage and inclusions in the final report

Regional Hub Performance

• North America held the largest share of the global single-use bioprocessing market in 2025. The region accounted for 7% of revenue, supported by its established pharmaceutical and biotechnology industries, strong research ecosystem, and significant investments in biologics manufacturing. The U.S. represents the leading country-level market in the region.
• The U.S. market benefits from the presence of major biopharmaceutical manufacturers and contract development and manufacturing organizations. Investments in monoclonal antibodies, vaccines, cell therapies, and advanced therapy medicinal products are increasing demand for flexible manufacturing technologies. Facility modernization and supportive regulatory conditions are also contributing to adoption.
• Europe is another important market, supported by a strong biotechnology ecosystem, strict quality standards, and increasing government investment in life sciences. The region's focus on biosimilars, personalized medicine, cell therapies, and advanced biologics is supporting the use of flexible bioprocessing technologies.
• Asia Pacific is expected to register the fastest growth during the forecast period. Increasing biopharmaceutical manufacturing capacity, rising healthcare expenditure, growing investment in biotechnology, and the expansion of pharmaceutical production in countries such as China, India, Japan, South Korea, and Australia are creating significant opportunities.

Pinpoint Key Market Drivers

The rising demand for biopharmaceutical products is the central driver of the single-use bioprocessing market. Biologics have become increasingly important in the treatment of cancer, autoimmune disorders, infectious diseases, and other complex conditions. As production volumes increase, manufacturers require efficient systems capable of supporting different manufacturing scales.

Another important factor is reduced contamination risk. Single-use components are supplied ready for use and can minimize the need for extensive cleaning and sterilization between production batches. This can improve operational efficiency and reduce downtime.

Cost efficiency is also significant. Traditional stainless-steel facilities require substantial investment in cleaning systems, water systems, steam infrastructure, and validation. Single-use systems can reduce some of these infrastructure requirements and provide greater flexibility for manufacturers.

The growth of contract manufacturing organizations is another important driver. CDMOs can use single-use equipment to quickly adapt production facilities to different customer requirements, helping them support multiple products and production scales.

Looking for more specific insights? Customize this report to suite your business needs

Analyze Segment Metrics

By product, simple and peripheral elements accounted for 48.9% of market revenue in 2025, making this the leading category. This segment includes tubing, filters, connectors, transfer systems, bags, sensors, probes, and other peripheral components that are essential to single-use manufacturing workflows.

The apparatus and plants segment is expected to experience strong growth as manufacturers increasingly deploy complete single-use manufacturing systems. These solutions can include mixing, storage, filling, and other integrated capabilities.

By workflow, upstream processing held the largest share of 58.4% in 2025. Upstream processing includes activities such as cell cultivation and fermentation, where single-use bioreactors and related components are increasingly used.

By end use, biopharmaceutical manufacturers accounted for 57.9% of market revenue in 2025. Commercial success of biologics and increasing outsourcing to CROs and CMOs are supporting this segment. Contract manufacturers benefit from the flexibility, scalability, and reduced infrastructure requirements offered by single-use systems.

Academic and clinical research institutes are expected to grow at a strong pace as benchtop-scale bioprocessing equipment becomes more accessible. Research into cell and gene therapies and vector production is also supporting demand for flexible single-use technologies.

Identify Major Industry Players

The competitive landscape includes global bioprocessing technology companies, pharmaceutical technology suppliers, filtration specialists, and manufacturers of disposable components.

Major industry participants include:

• Sartorius AG
• Danaher Corporation
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Avantor, Inc.
• Eppendorf SE
• Corning Incorporated
• Boehringer Ingelheim International GmbH
• Lonza
• Infors AG
• PBS Biotech, Inc.

Latest Related Report Explores :

• Single-use Bioprocessing Market (2026 - 2033)
• US. Single-use Bioprocessing Market (2025 - 2030)
• Single-use Bioprocessing Probes & Sensors Market (2024 - 2030)
• Single-use Bioprocess Tubing And Assemblies Market (2026 - 2033)
• Single-use Pump Market (2026 - 2033)

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.